Company profile
Sunniva Inc.
OTC: SNNVF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#585 of 1,418 Healthcare companies by revenue63rd-percentile growth
EA Score
——FH —DQ —GM —SS 40
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, workforce scale · ↓ disclosure history, market scale
Methodology →Revenue TTM
$22.8M
Rev growth YoY (TTM)
+52.1%
Net income (FY)
-$22.4M
Employees
148
as of 2026-08-30
Market cap
$3.9k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$14.5M18.8M CAD2018
Net income-$22.4M-29.0M CAD2018
Operating income-$21.7M-28.1M CAD2018
Total assets$91.9M125.3M CAD2018
Liabilities$29.5M40.3M CAD2018
Equity$62.3M85.0M CAD2018
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Sunniva Inc.’s revenue?
Sunniva Inc. booked $14.5M in FY2018 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -154.6% net margin.
Peers · Healthcare
Allurion Technologies Inc.26DVSee Health, Inc.35DLineage Cell Therapeutics, Inc.56CUrologix, Inc.——Opus Genetics, Inc.39DArbutus Biopharma Corp61CKey facts
CEOAnthony F. Holler
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: SNNVF
Employees148
IPO date2018-01-11
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.